Citigroup’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-59,700
| Closed | -$10.7M | – | 7795 |
|
|
2017
Q3 | $10.7M | Buy |
59,700
+21,600
| +57% | +$3.01M | 0.01% | 1192 |
|
|
2017
Q2 | $3.95M | Buy |
38,100
+23,000
| +152% | +$1.88M | ﹤0.01% | 1912 |
|
|
2017
Q1 | $1.19M | Sell |
15,100
-7,900
| -34% | -$488K | ﹤0.01% | 3033 |
|
|
2016
Q4 | $1.03M | Sell |
23,000
-4,900
| -18% | -$240K | ﹤0.01% | 3662 |
|
|
2016
Q3 | $1.56M | Sell |
27,900
-44,600
| -62% | -$2.48M | ﹤0.01% | 2754 |
|
|
2016
Q2 | $3.63M | Buy |
72,500
+48,600
| +203% | +$2.39M | ﹤0.01% | 1863 |
|
|
2016
Q1 | $1.1M | Sell |
23,900
-500
| -2% | -$24.2K | ﹤0.01% | 3229 |
|
|
2015
Q4 | $1.5M | Sell |
24,400
-16,400
| -40% | -$1.15M | ﹤0.01% | 2717 |
|
|
2015
Q3 | $2.27M | Buy |
40,800
+6,700
| +20% | +$421K | ﹤0.01% | 2334 |
|
|
2015
Q2 | $2.08M | Buy |
34,100
+33,800
| +11,267% | +$1.93M | ﹤0.01% | 2480 |
|
|
2015
Q1 | $17K | Buy |
+300
| New | +$20.1K | ﹤0.01% | 6193 |
|
Citigroup's KITE Position: Q4 2017 in Review
Citigroup sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 356,484 shares — an estimated $64.1M sold.
Citigroup first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $64.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Citigroup reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Citigroup sold 356,484 Kite Pharma, Inc. shares in Q4 2017, an estimated $64.1M.
- Citigroup first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- Citigroup's Kite Pharma, Inc. position peaked at $64.1M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.